Non-interventional Study With NOVOCART® Inject in the Reconstruction of the Knee Cartilage Defects (RENOVO)
Retrospective Observational Study for Reconstruction of Localized, Full-thickness Cartilage Defects in the Knee Joint With In-situ Polymerizable and Chondrocyte Populated Biomaterial (NOVOCART® Inject)
Sponsor: Aesculap AG
A observational or N/A phase clinical study on Cartilage Disease, this trial is completed. The trial is conducted by Aesculap AG and has accumulated 9 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jan 2020 — Jan 2021 [monthly]
Completed
Status: Recruiting → Completed
-
Feb 2019 — Jan 2020 [monthly]
Recruiting
▶ Show 4 earlier versions
-
Jun 2018 — Feb 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Dec 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Aesculap AG
- Tetec AG
- Winicker Norimed GmbH
For direct contact, visit the study record on ClinicalTrials.gov .